|
|
|
5-HT2A receptor
|
|
|
Rn |
Antagonist |
Antagonist |
9.2 |
pKi |
- |
16-17 |
|
⤷ |
pKi
9.2
[16-17]
|
5-HT2B receptor
|
|
|
Hs |
Antagonist |
Antagonist |
8.7 – 9.2 |
pKi |
- |
6,10,16,20 |
|
⤷ |
pKi
8.7 – 9.2
[6,10,16,20]
|
5-HT2C receptor
|
|
|
Hs |
Antagonist |
Antagonist |
8.2 – 9.6 |
pKi |
- |
10 |
|
⤷ |
pKi
8.2 – 9.6
[10]
|
5-HT2A receptor
|
|
|
Hs |
Antagonist |
Antagonist |
8.3 – 9.4 |
pKi |
- |
10,16 |
|
⤷ |
pKi
9.4
[16]
pKi
8.3
[10]
|
α1A-adrenoceptor
|
|
|
Hs |
Antagonist |
Antagonist |
8.4 |
pKi |
- |
21 |
|
⤷ |
pKi
8.4
[21]
|
5-HT2B receptor
|
|
|
Rn |
Antagonist |
Antagonist |
8.3 |
pKi |
- |
19 |
|
⤷ |
pKi
8.3
[19]
|
α1B-adrenoceptor
|
|
|
Hs |
Antagonist |
Antagonist |
8.0 |
pKi |
- |
21 |
|
⤷ |
pKi
8.0
[21]
|
α1D-adrenoceptor
|
|
|
Hs |
Antagonist |
Antagonist |
7.8 |
pKi |
- |
21 |
|
⤷ |
pKi
7.8
[21]
|
5-HT7 receptor
|
|
|
Rn |
Antagonist |
Antagonist |
7.7 – 7.8 |
pKi |
- |
18 |
|
⤷ |
pKi
7.7 – 7.8
[18]
|
5-HT1D receptor
|
|
|
Hs |
Antagonist |
Antagonist |
7.6 |
pKi |
- |
14 |
|
⤷ |
pKi
7.6
[14]
|
5-HT5A receptor
|
|
|
Hs |
Antagonist |
Antagonist |
7.6 |
pKi |
- |
8 |
|
⤷ |
pKi
7.6
[8]
|
5-HT5A receptor
|
|
|
Mm |
Antagonist |
Antagonist |
7.4 |
pKi |
- |
8 |
|
⤷ |
pKi
7.4
[8]
|
5-HT6 receptor
|
|
|
Hs |
Antagonist |
Antagonist |
7.0 – 7.4 |
pKi |
- |
2,5,11 |
|
⤷ |
pKi
7.0 – 7.4
[2,5,11]
|
5-HT6 receptor
|
|
|
Rn |
Antagonist |
Antagonist |
6.5 – 7.8 |
pKi |
- |
3-5,15 |
|
⤷ |
pKi
6.5 – 7.8
[3-5,15]
|
5-HT7 receptor
|
|
|
Hs |
Antagonist |
Antagonist |
6.8 – 7.4 |
pKi |
- |
1,12 |
|
⤷ |
pKi
6.8 – 7.4
[1,12]
|
5-HT1B receptor
|
|
|
Hs |
Antagonist |
Antagonist |
6.0 – 6.5 |
pIC50 |
- |
7,13 |
|
⤷ |
pIC50
6.0 – 6.5
[7,13]
|
5-HT1A receptor
|
|
|
Hs |
Antagonist |
Antagonist |
5.2 – 5.5 |
pIC50 |
- |
9 |
|
⤷ |
pIC50
5.2 – 5.5
[9]
|
|